New program aims to protect cancer patients' hearts during active treatment

NCT ID NCT06834204

Not yet recruiting Disease control Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 01, 2026 · Updated 7 times

Summary

This study tests a program called Primary Care Connect (PC2) that helps cancer survivors with heart risks stay connected to their primary care doctor during cancer treatment. About 266 adults with early-stage breast, prostate, bladder, or endometrial cancer who also have high blood pressure, diabetes, or high cholesterol will take part. The goal is to see if the program improves management of these chronic conditions and reduces heart disease risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Rutgers RWJ Medical School

Somerset, New Jersey, 08901, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BLADDER CANCER BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) CANCER DIABETES MELLITUS ENDOMETRIAL CANCER ENDOMETRIAL CANCER HYPERLIPIDEMIA (E.G., HYPERCHOLESTEROLEMIA) HYPERTENSION PROSTATE CANCER (ADENOCARCINOMA)